I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
The Surrey Heartland Integrated Care System Area Prescribing Committee have agreed to adopt the SERMOG high-cost drugs pathway.for adiults with psoriasis
The PCN recommends Apremilast as a treatment option for moderate to severe plaque psoriasis in line with NICE TA419 (23rd November 2016). Apremilast is a payment by results excluded drug which will be considered RED on the traffic light system. The current psoriasis treatment pathway is available on the prescribing advisory database.
Other Indications
Below are listed other indications that Apremilast is used to treat.
